Answers are grounded in this paper and cite their sources.
Six series of quinazoline derivatives bearing oxazole or imidazole ( 8a–f , 9a–f , 10a–d , 11a–f , 12a–d and 13a–i ) were designed, synthesized and their IC ₅₀ values evaluated against three cancer cell lines (A549, MCF-7 and PC-3).
No takes yet. Share an insight, caveat, or question.
Ouyang et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: